A detailed history of Ameriprise Financial Inc transactions in Pfizer Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 18,253,080 shares of PFE stock, worth $501 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
18,253,080
Previous 18,540,204 1.55%
Holding current value
$501 Million
Previous $514 Million 0.73%
% of portfolio
0.14%
Previous 0.14%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $7.25 Million - $8.5 Million
-287,124 Reduced 1.55%
18,253,080 $511 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $56.7 Million - $65.1 Million
-2,189,208 Reduced 10.56%
18,540,204 $514 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $215 Million - $279 Million
8,223,229 Added 65.75%
20,729,412 $597 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $321 Million - $375 Million
-9,998,619 Reduced 44.43%
12,506,183 $415 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $30.9 Million - $35.7 Million
-855,359 Reduced 3.66%
22,504,802 $825 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $34 Million - $44.3 Million
863,374 Added 3.84%
23,360,161 $953 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $10.9 Million - $14.3 Million
262,117 Added 1.18%
22,496,787 $1.15 Billion
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $7.92 Million - $9.67 Million
180,952 Added 0.82%
22,234,670 $973 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $26.1 Million - $30.9 Million
-560,926 Reduced 2.48%
22,053,718 $1.16 Billion
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $200 Million - $247 Million
4,361,710 Added 23.9%
22,614,644 $1.17 Billion
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $16.7 Million - $24.8 Million
-404,892 Reduced 2.17%
18,252,934 $1.07 Billion
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $44.3 Million - $56.9 Million
1,129,497 Added 6.44%
18,657,826 $802 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $14.8 Million - $16.8 Million
-412,007 Reduced 2.3%
17,528,329 $687 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $317 Million - $357 Million
9,451,863 Added 111.35%
17,940,336 $650 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $293 Million - $373 Million
-8,765,378 Reduced 50.8%
8,488,473 $313 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $34.5 Million - $40.5 Million
-1,086,011 Reduced 5.92%
17,253,851 $633 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $51.7 Million - $62.7 Million
-1,715,171 Reduced 8.55%
18,339,862 $599 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $114 Million - $162 Million
-4,204,167 Reduced 17.33%
20,055,033 $655 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $20.6 Million - $23.4 Million
-626,413 Reduced 2.52%
24,259,200 $951 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $327 Million - $424 Million
-10,069,352 Reduced 28.81%
24,885,613 $894 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $24.8 Million - $27.8 Million
670,555 Added 1.96%
34,954,965 $1.51 Billion
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $393 Million - $432 Million
-10,474,871 Reduced 23.4%
34,284,410 $1.46 Billion
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $313 Million - $357 Million
-8,134,727 Reduced 15.38%
44,759,281 $1.95 Billion
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $76.4 Million - $92.7 Million
-2,217,128 Reduced 4.02%
52,894,008 $2.41 Billion
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $9.06 Million - $9.65 Million
274,595 Added 0.5%
55,111,136 $2 Billion
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $175 Million - $203 Million
-5,475,872 Reduced 9.08%
54,836,541 $1.95 Billion
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $15.6 Million - $16.5 Million
468,389 Added 0.78%
60,312,413 $2.18 Billion
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $1.86 Billion - $2.04 Billion
59,844,024
59,844,024 $2.14 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.